The PATfix®LNP Switcher Platform is an advanced analytical system designed for the characterization of lipid nanoparticle (LNP) formulations, supporting the development of nucleic acid therapeutics such as mRNA and pDNA vaccines. It provides comprehensive, high-resolution insights into critical quality attributes, including particle size, encapsulation efficiency, and nucleic acid integrity, adducts, providing researchers with insights during LNP formulation screening and manufacturing.
With its multi-detection capabilities, PATfix® LNP Switcher Platform needs no sample preparation, preserving the integrity of sensitive nucleic acid payloads. The PATfix® software is 21 CFR Part 11 compliant, supporting secure data capture and reproducible reporting.
